Demonstrating the capacity of the National Advisory Committee on Immunization for timely responses to post-market vaccine monitoring signals: Canada’s experience with the live-attenuated influenza vaccine
Over the last several years, the recommended use of the live-attenuated influenza vaccine (LAIV) for children has evolved in the United States (US) in response to evidence of a potential decrease in LAIV effectiveness based on post-market monitoring. These issues were not observed in Canada or elsew...
Main Authors: | Linlu Zhao, Kelsey Young, Althea House, Rob Stirling, Matthew Tunis |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Health Agency of Canada
2021-05-01
|
Series: | Canada Communicable Disease Report |
Subjects: | |
Online Access: | https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-5-6-may-june-2021/national-advisory-committee-immunization-recommendations-post-market-vaccine-live-attenuated-influenza-vaccine.html |
Similar Items
-
The safety of attenuated and recombinant nasal influenza vaccines in terms of the development of secondary bacterial superinfection
by: N. R. Makhmudova, et al.
Published: (2019-12-01) -
Development of a Novel Live Attenuated Influenza A Virus Vaccine Encoding the IgA-Inducing Protein
by: C. Joaquín Cáceres, et al.
Published: (2021-06-01) -
Mutation E48K in PB1 Polymerase Subunit Improves Stability of a Candidate Live Attenuated Influenza B Virus Vaccine
by: Jongsuk Mo, et al.
Published: (2021-07-01) -
FluB-RAM and FluB-RANS: Genome Rearrangement as Safe and Efficacious Live Attenuated Influenza B Virus Vaccines
by: Stivalis Cardenas-Garcia, et al.
Published: (2021-08-01) -
Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in England
by: Dominic Thorrington, et al.
Published: (2017-09-01)